Okomera
PrivateLast Round
Grant
Oct 21, 2024
Total Funding Raised
$12.8M
Company Overview
Okomera is a biotechnology research company that develops an automated organoid screening platform using microfluidics and AI to accelerate drug discovery and personalized cancer treatments.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Okomera Comparables
Compare Okomera with similar companies based on industry and business-model similarity.
Okomera Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 21, 2024 | ||||
| Seed | Dec 20, 2023 |
Key People
Founding team and executive leadership
Okomera Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Berkeley SkyDeck | Seed |
| Resonance | Seed |
| Bpifrance | Grant |
| IQ-EQ | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 17, 2025
Grew 19% QoQ, from 27 to 32 employees.
- Mar 22, 2025
Monthly visitors grew 189% MoM, from 485 to 1.4K.
Okomera Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Okomera's valuation, stock price, and market status.